Page 638 - 16Neonatal Jaundice_compressed

Appendix J: Excluded studies

Reference Reason for exclusion
Gourley GR. Another risk factor for neonatal hyperbilirubinemia. Journal of Pediatric Gastroenterology and Nutrition 2005; Synospis
40:(3)388–9.
Grupp-Phelan J, Taylor JA, Liu LL et al. Early newborn hospital discharge and readmission for mild and severe jaundice. Archives Effect of early discharge on jaundice readmission
of Pediatrics and Adolescent Medicine 1999; 153:(12)1283–8. rates
Guo X, Pu X, An T et al. Characteristics of brainstem auditory evoked potential of neonates with mild or moderate No comparison group
hyperbilirubinemia. Neural Regeneration Research 2007; 2:(11)660–4.
Hall RT, Simon S, and Smith MT. Readmission of breastfed infants in the first 2 weeks of life. Journal of Perinatology 2000; Risk factors for readmission of breastfed babies
20:(7)432–7.
Harris MC, Bernbaum JC, Polin JR et al. Developmental follow-up of breastfed term and near-term infants with marked Developmental follow-up of babies with bilirubin
hyperbilirubinemia. Pediatrics 2001; 107:(5)1075–80. > 451 micromol/litre
Huang MJ, Kua KE, Teng HC et al. Risk factors for severe hyperbilirubinemia in neonates. Pediatric Research 2004; 56:(5)682–9. Only breastfeeding and genetic risk factors
considered
Iranpour R, Akbar MR, and Haghshenas I. Glucose-6-Phosphate Dehydrogenase Deficiency in Neonates. Indian Journal of G6PD deficiency as a risk factor for jaundice
Pediatrics 2003; 70:(11)855–7.
Johnson L. Hyperbilirubinemia in the term infant: When to worry, when to treat. New York State Journal of Medicine 1991; Overview
91:(11)483–9.
Kaplan M, Bromiker R, Schimmel MS et al. Evaluation of discharge management in the prediction of hyperbilirubinemia: the Effect of discharge management on readmission
Jerusalem experience. Journal of Pediatrics 2007; 150:(4)412–7. rates
Kaplan M, Herschel M, Hammerman C et al. Neonatal hyperbilirubinemia in African American males: the importance of glucose- Study restricted to African-American males babies
6-phosphate dehydrogenase deficiency. Journal of Pediatrics 2006; 149:(1)83–8.
Madlon-Kay DJ. The clinical significance of ABO blood group incompatibility. Archives of Family Medicine 1993; 2:(3)285–7. ABO incompatibility as a risk factor for jaundice
Maisels MJ and Kring E. Length of stay, jaundice, and hospital readmission. Pediatrics 1998; 101:(6)995–8. Risk factors for readmission for jaundice –
confounders not controlled for
Nakamura H. Assessing the risk of kernicterus. Indian Journal of Pediatrics 1987; 54:(5)625–31. Unbound bilirubin as a risk factor for kernicterus
Ogun B, Serbetcioglu B, Duman N et al. Long-term outcome of neonatal hyperbilirubinaemia: subjective and objective Long-term sequelae of hyperbilirubinaemia
audiological measures. Clinical Otolaryngology and Allied Sciences 2003; 28:(6)507–13.
Olusanya BO, Akande AA, Emokpae A et al. Infants with severe neonatal jaundice in Lagos, Nigeria: Incidence, correlates and Effect of severe neonatal jaundice on hearing
hearing screening outcomes. Tropical Medicine and International Health 2009; 14:(3)301–10. outcomes
Paul IM, Lehman EB, Hollenbeak CS et al. Preventable newborn readmissions since passage of the Newborns' and Mothers' Predictors of readmission after hospital discharge
Health Protection Act. Pediatrics 2006; 118:(6)2349–58.
Paul IM, Phillips TA, Widome MD et al. Cost-effectiveness of postnatal home nursing visits for prevention of hospital care for Not relevant to this quideline
jaundice and dehydration. Pediatrics 2004; 114:(4)1015–22.
Phuapradit W, Chaturachinda K, and Auntlamai S. Risk factors for neonatal hyperbilirubinemia. Journal of the Medical No regression analysis
Association of Thailand 1993; 76:(8)424–8.
Sales de Almeida F, Pialarissi PR, Monte AA et al. Otoacoustic emissions and ABR: Study in hyperbilirubinemic newborns. Revista Outcome not of interest to this guideline
Brasileira de Otorrinolaringologia 2002; 68:(6)851–7.

463